Read More Pharma Industry News Omeros seeks EMA approval for narsoplimab to treat stem cell transplant-related TA-TMA Omeros Corporation has submitted a Marketing Authorization Application to the EMA for narsoplimab, aiming to treat TA-TMA across Europe. Learn what’s at stake. byPallavi MadhirajuJune 29, 2025